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Abstract 
Fulminant hepatic failure is characterized by the presence of hepatic encephalopathy in 
the setting of acute liver injury that occurs in a noncirrhotic organ. Brain edema is the 
ultimate complication of advanced hepatic encephalopathy as it often leads to cerebral 
herniation and death. Thus, the presence of fulminant hepatic failure indicates the need 
for urgent liver transplantation to prevent death or irreversible brain damage. We report 
a very unusual evolution of fulminant hepatic failure complicated by brain edema and 
hepatic coma in a 45-year-old woman admitted with acute viral hepatitis E infection. 
 
Case Report 
A 45-year-old woman was admitted to our hospital 9 days after the apparition of asthenia and 
progressive jaundice. She was working as a nutritionist in the Darfur region of western Sudan, had no 
personal or family history of liver disease and was not consuming illicit drugs or alcohol. She had 
received hepatitis A and B vaccines. The day prior to transfer in Geneva, she developed grade IV 
hepatitis E, was electively intubated and given intravenous mannitol. Computed tomography showed a 
grossly normal liver with patent hepatic veins and ascites. Diffuse cerebral edema was evident both at 
cranial computed tomography and MRI scans (fig. 1). Laboratory values were as follows: aspartate 
aminotransferase 436 IU/l (N: 1–42), alanine aminotransferase 1,813 IU/l (N: 9–42), total bilirubin 
436 μmol/l (N: 7–25), alkaline phosphatase 107 IU/l (N: 30–125), ammonium 118 μmol/l (N: 11–35), 
creatinine 72 μmol/l (N: 35–88), phosphate 0.63 mmol/l (N: 0.8–1.5), prothrombin time 59 s, INR 6, 
and factor V 20%. Alpha fetoprotein level was 219 ng/ml (N: <15). She tested negative for autoimmune, 
toxic and metabolic diseases as well as for hepatitis A, B, C, and HIV. However, high titers of anti-HEV 
antibodies (enzyme immunoassay Abbott HEV EIA) were detected in the serum. The levels of anti-HEV 
IgG and IgM were 3,000 (threshold level at 520) and 1,848 (threshold level at 420) optical densities,  
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respectively. There was no evidence of infection. Thus, in the presence of acute liver failure (factor V 
<30%) complicated by rapid neurological deterioration and brain edema on imaging studies, 
spontaneous survival was estimated below 10% according to Clichy’s criteria [1], and the patient was 
listed for urgent liver transplantation while receiving standard supportive care but no hypothermia or 
liver support device. She remained stable during the two following days and progressively started to 
breathe spontaneously and to respond to painful stimuli. Figure 1 illustrates the spontaneous 
progressive improvement in biological tests starting from day 2 of hospital admission. She was then 
delisted. On day 4, she was fully conscious and oriented. Brain edema had completely resolved on repeat 
cranial MRI. The neurological status was normal at hospital discharge on day 22. 
Discussion 
Hepatitis E virus is a frequent cause of acute hepatitis in developing countries [2]. High 
mortality was initially described in pregnant women from endemic countries, but 
sporadic cases [3], sometimes fatal [4], have been described both in males and 
nonpregnant females from Western Europe. In acute liver failure, prognostic markers that 
dictate the need for urgent liver transplantation include the King’s College and Clichy’s 
criteria [1], and more recently the MELD [5]. Our patient fulfilled all these criteria. 
Although useful, these tools are not 100% accurate in predicting spontaneous outcome. 
Factors that may positively influence the course of the hepatitis include viral cause, 
hyperacute presentation, elevated AFP and no infection, while the presence of profound 
hepatitis E complicated by cerebral edema is clearly associated with a poor prognosis 
without urgent liver transplantation. 
Whether the particular evolution of our case with fulminant hepatic failure relates to 
host factors or to the causative agent remains unclear. Neurological symptoms associated 
with hepatitis E include meningoencephalitis with seizures [6] and spontaneously 
reversible grade III hepatitis E in the setting of both acute liver and renal failure [7]. The 
combined action of acute hepatitis and associated hyperammonemia-induced increased 
permeability of the blood brain barrier may increase the risk of hepatitis E and brain 
edema [8]. 
Although the present case underlines the limitations of prognostic scoring in this 
life-threatening condition, the treatment of patients with fulminant hepatic failure 
remains urgent liver transplantation [9]. 
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Fig. 1. Evolution of laboratory values over time since hospital admission in Geneva. 
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